EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomic Profiling of Extracellular Vesicles in Inflammatory Bowel Diseases

Montse Baldán-Martín iD, Mikel Azkargorta, Ainhoa Lapitz, Lorena Ortega Moreno iD, Ibon Iloro, Samuel Fernández-Tomé iD, Ander Arbelaiz, Iraide Escobes, Alicia C Marín, David Bernardo iD, Luis Bujanda, Jesús M Bañales und 3 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26020526 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Montse Baldán-Martín und 14 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Investigación Sanitaria Princesa (IIS-Prince…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Proteomics, Colitis, Ulcerative, Crohn Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GETECCU, ECCO, AEG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The proteomic analysis of serum extracellular vesicles (EVs) could be a useful tool for studying the pathophysiology of Crohn’s disease (CD) and ulcerative colitis (UC), as well as for biomarker discovery. To characterize the proteomic composition of serum EVs in patients with CD and UC to identify biomarkers and molecular pathways associated with pathogenesis and activity. Methods: Serum EVs were enriched and analyzed in patients with quiescent CD, active CD (aCD), quiescent UC, active UC (aUC), and healthy controls (HCs) (n = 30 per group). All groups were matched for age and sex. Disease activity was assessed by ileocolonoscopy and categorized based on the SES-CD (CD) and the endoscopic sub-score of the Mayo Score (UC). EVs were enriched by ul-tracentrifugation, and their size and concentration were determined by nanoparticle tracking analysis. The expression of CD63, CD81, and CD9 was determined using West-ern blotting. Proteomic analysis was performed by label-free nano-LC MS/MS. A total of 324 proteins were identified; 60 showed differential abundance in CD-HC, 34 in UC-HC, and 21 in CD-UC. Regarding disease activity, the abundance of 58 and 32 proteins was altered in aCD-HC and aUC-HC, respectively. Functional analyses revealed that proteins associated with aCD were involved in immune regulation, whereas those linked to aUC were enriched in oxidative stress. We have identified expressed proteins between EVs from patients with CD and UC, depending on the presence of disease, the disease type, and the disease activity. These proteins are potential candidates as disease biomarkers and open new research avenues to better understand these conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesProteomicsColitis, UlcerativeCrohn DiseaseProteomeInflammatory Bowel DiseasesHumansMaleFemaleAdultBiomarkersMiddle AgedCase-Control Studies

Stichwörter der Autor:innen

Crohn’s diseaseextracellular vesiclesproteomicsulcerative colitis

Substanzen

BiomarkersProteome

Autor:innen und Institutionen

  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Hospital Universitario de La Princesa, Universidad Autónoma de Ma…
  • Proteomics Platform, CIC bioGUNE, BRTA (Basque Research & Technology Alliance), CIBEREHD, 48160 Derio, Spain.
  • Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute-Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014 Donostia-San Sebastian, Spain.
  • National Institute for the Study of Liver and Gastrointestinal Diseases (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Área de Farmacología y Nutrición y Bromatología, Grupo de Investigación de Alto Rendimiento en Fisiopatología del Sistema Digestivo URJC: NeuGut-URJC, Departamento Ciencias Básicas de la Salud, Universidad Rey Juan Carl…
  • Departamento de Nutrición y Ciencia de los Alimentos, Facultad de Farnmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain.

ORCID-Profile: Montse Baldán-Martín, Lorena Ortega Moreno, Samuel Fernández-Tomé, David Bernardo, Felix Elortza, Javier P Gisbert, María Chaparro

Förderung

  • GETECCU
  • ECCO
  • AEG
  • CSIC´s Global Health Platform
  • Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU)
  • XX (Beca GETECCU-Faes Farma)
  • European Crohn’s and Colitis Organisation (ECCO)
  • Asociación Española de Gastroenterología (Beca Gonzalo Miño)

Zitieren

APA

Baldán-Martín, M., Azkargorta, M., Lapitz, A., Ortega Moreno, L., Iloro, I., Fernández-Tomé, S., Arbelaiz, A., Escobes, I., Marín, A. C., Bernardo, D., Bujanda, L., Bañales, J. M., Elortza, F., Gisbert, J. P., & Chaparro, M. (2025). Proteomic Profiling of Extracellular Vesicles in Inflammatory Bowel Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020526

Vancouver

Baldán-Martín M, Azkargorta M, Lapitz A, Ortega Moreno L, Iloro I, Fernández-Tomé S, et al. Proteomic Profiling of Extracellular Vesicles in Inflammatory Bowel Diseases. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020526

BibTeX
@article{BaldnMartn2025,
  author = {Baldán-Martín, Montse and Azkargorta, Mikel and Lapitz, Ainhoa and Ortega Moreno, Lorena and Iloro, Ibon and Fernández-Tomé, Samuel and Arbelaiz, Ander and Escobes, Iraide and Marín, Alicia C and Bernardo, David and Bujanda, Luis and Bañales, Jesús M and Elortza, Felix and Gisbert, Javier P and Chaparro, María},
  title = {Proteomic Profiling of Extracellular Vesicles in Inflammatory Bowel Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26020526}
}
Kostenlos starten →